Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 406
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02344472 | Detect V / CHEVENDO (Chemo vs. Endo) | ||
| NCT00855894 | A Study of the Combination of Erlotinib and Pertuzumab in Patients With Relapsed Non-small Cell Lung Cancer | ||
| NCT03911219 | Impact of eHealth Monitoring on Overall Survival in Patients With Metastatic NSCLC / Extensive-stage SCLC / Advanced TNBC Under First-line Treatment With Atezolizumab Plus Chemotherapy | ||
| NCT00227370 | Comparison of Oral Valganciclovir and Placebo for the Prevention of Cytomegalovirus (CMV) After Lung Transplantation | ||
| NCT02433522 | Comparison Between a Long Term and a Conventional Maintenance Treatment With Rituximab | ||
| NCT01321957 | Efficacy of FOLFOX+Bevacizumab in Combination With Irinotecan in the Treatment of Metastatic Colorectal Cancer | ||
| NCT00316420 | Gemcitabine and Capecitabine in Patients With Advanced Pancreatic Cancer | ||
| NCT00411762 | A Phase I/II, Multi-Center, Open-Label, Dose-Escalation, Safety and Efficacy Study of PHY906 Plus Capecitabine in Patients With Advanced Pancreatic Carcinoma | ||
| NCT07336134 | PopSci CHW4CervixHealth | ||
| NCT00562952 | Nt-proBNP Guided Primary Prevention of CV Events in Diabetic Patients | ||
| NCT03784599 | T-DM1 and Osimertinib Combination Treatment to Target HER2 Bypass Track Resistance in EGFR Mutation Positive NSCLC | ||
| NCT03487900 | Is the Endoscopic Remission Evaluation, Using the CREDO 1 Index / Score in CD Patients in Clinical Remission at Baseline, Predictive of Sustained Clinical Remission Using a 2-year Follow up | ||
| NCT01729481 | Gemcitabine Plus Erlotinib in RASH-positive Patients With Metastatic Pancreatic Cancer | ||
| NCT02622581 | Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients | ||
| NCT04470947 | Comprehensive Genomic Profiling and Next Generation Functional Drug Screening for Patients With Aggressive Haematological Malignancies | ||
| NCT03802604 | Combination of Talimogene Laherparepvec With Atezolizumab in Early Breast Cancer | ||
| NCT01428414 | Efficacy and Safety Study of Trastuzumab and Paclitaxel Based Regimens to Treat HER2-positive Breast Cancer | ||
| NCT03301493 | Genomic Testing and Resulting Medical Decisions | ||
| NCT01195298 | Bevacizumab and Capecitabine in Treatment of Elderly Patients With Metastatic Breast Cancer | ||
| NCT01167049 | Xeloda Plus Paclitaxel in Gastric Cancer With Liver Metastasis | ||
| NCT01249638 | Cap+Bev vs Cap+Iri+Bev 1st-line Therapy in mCRC | ||
| NCT03721484 | CINtec PLUS Triage in HPV Primary Screening | ||
| NCT00333385 | Continuous Versus Short Infusions of Ceftazidime in Cystic Fibrosis | ||
| NCT03697850 | Atezolizumab After Chemo-radiotherapy for MIBC Patients Not Eligible for Radical Cystectomy | ||
| NCT01208896 | Allogeneic Hematopoietic Stem Cell Transplantation After Reduced-intensity Conditioning for Relapsed Follicular Lymphoma | ||
| NCT03224208 | Vemurafenib Plus Cobimetinib in Advanced or Metastatic Melanoma Patients | ||
| NCT05971108 | Real-world Elecsys® GAAD Implementation and Validation to Improve Surveillance and Early Detection of HCC | ||
| NCT06191068 | Canadian CHO-KLAT/H-FIT Study - Quality of Life of, and Burden of Caring for, Persons With Hemophilia | ||
| NCT00262717 | Can Resistance Enhance Selection of Treatment? (CREST) | ||
| NCT00396435 | Correction of Anaemia and Progression of Renal Failure on Transplanted Patients | ||
| NCT05017142 | Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD) | ||
| NCT01220596 | Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B. | ||
| NCT03421288 | Study of Atezolizumab + FLOT vs. FLOT Alone in Patients With GC/GEJ and High Immune Responsiveness | ||
| NCT00620269 | Induction Chemotherapy Followed by CCRT According to EGFR Mutation Status in NSCLC III | ||
| NCT03197805 | Assessment of the Impact of RNA Genomic Profile on Treatment Decision-making in HER2 Equivocal Breast Cancer Patients | ||
| NCT00335595 | Study of Bevacizumab Alone or Combined With Capecitabine and Oxaliplatin as Support Therapy in Metastatic Colorectal Cancer Patients | ||
| NCT04245085 | ABC-lung: Atezolizumab, Bevacizumab and Chemotherapy in EGFR-mutant Non-small Cell Lung Carcinoma | ||
| NCT04387890 | Serologic Surveillance for SARS-CoV-2 (COVID-19) in a Prospective Cohort of Health Care Workers | ||
| NCT00952003 | Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients | ||
| NCT05754502 | Observational Study of Effectiveness and Safety of Trastuzumab Emtansine (T-DM1) in HER2-positive Breast Cancer Patients With Residual Invasive Disease Following Neoadjuvant Chemotherapy and Anti-HER2 Target Therapy | ||
| NCT01502267 | Desensitization Protocol for Highly Sensitized Patients on the Waiting List for Kidney Transplant | ||
| NCT00938444 | Evaluation of the BRADA and ABILHAND Questionnaires | ||
| NCT02511756 | Visualization of Anti-angiogenic Effects With Perfusion Computed Tomography (CTP) | ||
| NCT04148066 | ctDNA Guided Treatment of Early Resistance to Targeted Treatment | ||
| NCT06068998 | Molecular Characterization of Penile Cancers in Developing Countries | ||
| NCT00275132 | Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | ||
| NCT00347438 | Capecitabine as NeoAdjuvant Therapy in Locally Advanced Breast Cancer | ||
| NCT01118234 | Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) | ||
| NCT01226771 | Ribavirin Loading Dose or Priming and Concentration Targeting for HCV Genotype 1 | ||
| NCT00205556 | Effect of Increased Convective Clearance by On-Line Hemodiafiltration on All Cause Mortality in Chronic Hemodialysis Patients |
